Home/Filings/4/0001415889-25-022301
4//SEC Filing

Exter Neil 4

Accession 0001415889-25-022301

CIK 0001842295other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 4:15 PM ET

Size

5.5 KB

Accession

0001415889-25-022301

Insider Transaction Report

Form 4
Period: 2025-08-17
Exter Neil
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-08-17+16,00016,000 total
    Exercise: $13.35Exp: 2035-08-16Common Stock (16,000 underlying)
Footnotes (1)
  • [F1]The option vested as to 1/16th of the total award on March 3, 2025, and thereafter vested or vests as to an additional 1/16th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Issuer

Maze Therapeutics, Inc.

CIK 0001842295

Entity typeother

Related Parties

1
  • filerCIK 0001620014

Filing Metadata

Form type
4
Filed
Aug 18, 8:00 PM ET
Accepted
Aug 19, 4:15 PM ET
Size
5.5 KB